​

Immuneering Ownership | Who Owns Immuneering?


OverviewForecastFinancialsChartTranscripts

Immuneering Ownership Summary


Immuneering is owned by 78.38% institutional investors, 13.82% insiders, and 7.80% retail investors. Fmr is the largest institutional shareholder, holding 14.21% of IMRX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.22% of its assets in Immuneering shares.

IMRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmuneering78.38%13.82%7.80%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr9.19M14.21%$37.65M
Blackrock funding, inc. /de4.87M7.53%$19.95M
Vanguard group2.57M6.47%$16.90M
Price t rowe associates inc /md/1.94M4.40%$9.66M
Exoduspoint capital management, lp1.52M4.22%$10.62M
Sanofi2.71M4.19%$11.09M
Vanguard capital management2.28M3.53%$9.36M
Logos global management lp950.00K2.64%$6.65M
Geode capital management1.37M2.12%$5.63M
Blackrock533.36K1.82%$682.71K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Southport management272.50K7.87%$1.91M
Sanofi2.71M1.76%$11.09M
Alethea capital management472.94K0.99%$1.94M
Dcf advisers862.50K0.80%$3.53M
Occam crest management lp324.70K0.71%$1.33M
Logos global management lp950.00K0.60%$6.65M
Pvg asset management146.45K0.42%$730.79K
Flower city capital55.03K0.12%$274.60K
Prosight management, lp150.00K0.12%$614.25K
Exoduspoint capital management, lp1.52M0.11%$10.62M

Top Buyers

HolderShares% AssetsChange
Exoduspoint capital management, lp1.52M0.11%1.52M
Logos global management lp950.00K0.60%950.00K
Abrdn784.95K0.00%784.95K
Blackrock funding, inc. /de4.87M0.00%497.41K
Nuveen869.39K0.00%431.03K

Top Sellers

HolderShares% AssetsChange
Cormorant asset management, lp---3.30M
Empery asset management, lp---2.67M
Blackrock533.36K--843.76K
Millennium management330.40K0.00%-772.31K
Blue owl capital lp---665.00K

New Positions

HolderShares% AssetsChangeValue
Exoduspoint capital management, lp1.52M0.11%1.52M$10.62M
Logos global management lp950.00K0.60%950.00K$6.65M
Abrdn784.95K0.00%784.95K$3.21M
Gendell jeffrey l387.77K0.02%387.77K$1.59M
Two sigma advisers, lp248.70K0.00%248.70K$318.34K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Nisa investment advisors-10.00
Point72 (difc)-16.00
Jones financial companies lllp-30.00
Sbi securities-74.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202611715.84%34,496,07117.71%781.77%7323.73%215.00%
Mar 31, 202651-45.16%6,458,494-79.66%140.23%31-47.46%8-33.33%
Dec 31, 202564-7.25%18,176,982-30.34%450.87%43-24.56%928.57%
Sep 30, 20256874.36%26,041,962580.01%7262.29%56194.74%716.67%
Jun 30, 20253914.71%3,829,641-14.87%106.72%1946.15%6-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S4.02M6.22%-
HBM Healthcare Investments AG Ord3.65M5.63%-
Fidelity Growth Company Fund2.94M4.54%-
State Street® SPDR® S&P® Biotech ETF2.18M3.37%12.07K
Vanguard MStar Total Stk Mkt Idx Invest1.62M2.51%-
Vanguard Morn Total Stk Mkt Idx Investor1.62M2.51%-
Vanguard Total Stock Mkt Idx Inv1.62M2.51%-
iShares Russell 2000 ETF1.38M2.14%-
Fidelity Select Biotechnology1.10M1.69%-
US Small-Cap Growth II Equity Comp906.76K1.40%215.29K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 23, 2026Zeskind Benjamin J. PRESIDENT AND CEOBuy$10.95K
Jun 15, 2026Hall Brett Matthew CHIEF SCIENTIFIC OFFICERBuy$25.05K
Jan 16, 2026Brakewood Harold Eugene Chief Business OfficerBuy$24.99K
Jan 15, 2026Schall Thomas J.-Buy$101.04K
Jan 15, 2026Hall Brett Matthew CHIEF SCIENTIFIC OFFICERBuy$10.50K

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3--
2026 Q22-
2026 Q15-
2025 Q44-

IMRX Ownership FAQ


Who Owns Immuneering?

Immuneering shareholders are primarily institutional investors at 78.38%, followed by 13.82% insiders and 7.80% retail investors. The average institutional ownership in Immuneering's industry, Biotech Stocks , is 385.89%, which Immuneering falls below.

Who owns the most shares of Immuneering?

Immuneering’s largest shareholders are Fmr (9.19M shares, 14.21%), Blackrock funding, inc. /de (4.87M shares, 7.53%), and Vanguard group (2.57M shares, 6.47%). Together, they hold 28.21% of Immuneering’s total shares outstanding.

Does Blackrock own Immuneering?

Yes, BlackRock owns 1.82% of Immuneering, totaling 533.36K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 682.71K$. In the last quarter, BlackRock decreased its holdings by -844K shares, a -61.27% change.

Who is Immuneering’s biggest shareholder by percentage of total assets invested?

Southport management is Immuneering’s biggest shareholder by percentage of total assets invested, with 7.87% of its assets in 272.5K Immuneering shares, valued at 1.91M$.

Who is the top mutual fund holder of Immuneering shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Immuneering shares, with 6.22% of its total shares outstanding invested in 4.02M Immuneering shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools